Dan Brennan
Stock Analyst at TD Securities
(3.99)
# 556
Out of 4,876 analysts
107
Total ratings
50%
Success rate
11.56%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Buy | $56 → $60 | $50.86 | +17.97% | 2 | May 1, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $135 → $110 | $91.10 | +20.75% | 4 | May 1, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $8 → $2.5 | $2.47 | +1.21% | 4 | Mar 21, 2025 | |
| TEM Tempus AI | Reinstates: Buy | $74 | $66.52 | +11.24% | 2 | Feb 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $86 | $53.65 | +60.30% | 6 | Nov 26, 2024 | |
| NTRA Natera | Maintains: Buy | $155 → $175 | $167.96 | +4.19% | 4 | Nov 13, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $240 → $250 | $150.01 | +66.66% | 5 | Nov 7, 2024 | |
| BRKR Bruker | Maintains: Hold | $72 → $70 | $41.80 | +67.46% | 1 | Nov 6, 2024 | |
| ILMN Illumina | Maintains: Buy | $166 → $177 | $94.79 | +86.73% | 12 | Nov 5, 2024 | |
| RVTY Revvity | Maintains: Buy | $141 → $144 | $97.82 | +47.21% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $363 → $410 | $352.41 | +16.34% | 3 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $315 | $198.80 | +58.45% | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $153 → $160 | $119.17 | +34.26% | 12 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $5.25 | +471.43% | 1 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $13.53 | +129.12% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $648 → $658 | $408.28 | +61.16% | 12 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $42.31 | +20.54% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2.8 | $0.25 | +1,018.66% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $20 | $7.17 | +178.94% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $11.73 | +172.80% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $235.02 | +132.32% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $2.29 | +205.68% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.29 | +1,062.79% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $144.56 | +60.49% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,184.54 | -25.71% | 3 | Oct 7, 2020 |
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $56 → $60
Current: $50.86
Upside: +17.97%
GeneDx Holdings
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $91.10
Upside: +20.75%
Maravai LifeSciences Holdings
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $2.47
Upside: +1.21%
Tempus AI
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $66.52
Upside: +11.24%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $82 → $86
Current: $53.65
Upside: +60.30%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $167.96
Upside: +4.19%
Charles River Laboratories International
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $150.01
Upside: +66.66%
Bruker
Nov 6, 2024
Maintains: Hold
Price Target: $72 → $70
Current: $41.80
Upside: +67.46%
Illumina
Nov 5, 2024
Maintains: Buy
Price Target: $166 → $177
Current: $94.79
Upside: +86.73%
Revvity
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $97.82
Upside: +47.21%
Nov 4, 2024
Maintains: Hold
Price Target: $363 → $410
Current: $352.41
Upside: +16.34%
Oct 23, 2024
Maintains: Buy
Price Target: $310 → $315
Current: $198.80
Upside: +58.45%
Aug 22, 2024
Maintains: Buy
Price Target: $153 → $160
Current: $119.17
Upside: +34.26%
Aug 7, 2024
Maintains: Hold
Price Target: $28 → $30
Current: $5.25
Upside: +471.43%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $13.53
Upside: +129.12%
Jul 25, 2024
Maintains: Buy
Price Target: $648 → $658
Current: $408.28
Upside: +61.16%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $42.31
Upside: +20.54%
May 13, 2024
Initiates: Buy
Price Target: $2.8
Current: $0.25
Upside: +1,018.66%
May 1, 2024
Maintains: Buy
Price Target: $21 → $20
Current: $7.17
Upside: +178.94%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $11.73
Upside: +172.80%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $235.02
Upside: +132.32%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $2.29
Upside: +205.68%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.29
Upside: +1,062.79%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $144.56
Upside: +60.49%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,184.54
Upside: -25.71%